The PI3K- protein kinase B (AKT)-mammalian target of rapamycin (mTOR) axis is frequently hyperactivated during tumor progression, which can induce the overexpression of hexokinase 2 (HK2) and glucose transporter 1 (GLUT1), thereby sustaining a high glycolysis flux 47. Here, HK2 is linked to neoplasm.